BioMed X Innovation Center and Merck Serono have extended their collaboration to develop unique innovation models between academia and industry. Merck Serono extended the funding of the first two international research groups for a third year. Under BioMed X and Merck’s innovation model, outstanding life science talents from leading academic institutions worldwide were selected to work on metabolism and signaling in cancer, on tools to improve the selectivity of kinase inhibitors and on new ...